SCHEMBL9204659

SCHEMBL9204659

C=C(C(=O)OCC)c1ccncc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.47
▸ KMT2A Q03164 4/20 0.47
▸ MAPT P10636 3/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ KDM4E B2RXH2 4/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ CDC7 O00311 2/20 0.44
▸ DBF4 Q9UBU7 2/20 0.44
▸ TSHR P16473 1/20 0.43
▸ HTT P42858 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ PKN1 Q16512 1/20 0.41
▸ PKN2 Q16513 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ NAPRT Q6XQN6 1/20 0.41
▸ NAMPT P43490 2/20 0.40
▸ MPO P05164 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ ADORA3 P0DMS8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27268475 0.88 LMNA (0.43) ALDH1A1KMT2ANPSR1KDM4ETSHR
SCHEMBL5059081 0.87 MAPT (0.55) ALDH1A1KMT2AMAPTNPSR1MEN1
SCHEMBL3933998 0.81 KMT2A (0.50) ALDH1A1KMT2AMAPTNPSR1KDM4E
SCHEMBL5086187 0.81 ALDH1A1 (0.50) ALDH1A1KMT2AMAPTTSHRHTT
SCHEMBL316956 0.81 ALDH1A1 (0.69) ALDH1A1KMT2AMAPTMEN1TSHR
SCHEMBL27929947 0.81 HCAR2 (0.46) ALDH1A1KMT2AMAPTKDM4EMEN1
SCHEMBL6783785 0.80 L3MBTL1 (0.52) ALDH1A1KMT2AMAPTKDM4EMEN1
SCHEMBL29640466 0.80 L3MBTL1 (0.52) ALDH1A1KMT2AMAPTKDM4EMEN1
SCHEMBL2491603 0.80 CA12 (0.61) ALDH1A1KMT2AMAPTMEN1TSHR
SCHEMBL6718454 0.80 ALDH1A1 (0.53) ALDH1A1KMT2AMAPTMEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116490507-A Heterocyclic condensation CDC7 kinase inhibitors for the treatment of cancer 薛定谔公司 2023-07-25 — — CN disclosed
CN-1036458-C Condensed heterocyclic compouds, their production and use — 1997-11-19 — — CN disclosed
US-5441967-A Treating cerebral edema; anticholinesterase or brain function-improving agent TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-08-15 — — US disclosed
EP-0487071-B1 Condensed heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1995-07-05 — — EP disclosed
US-5294625-A 1-benzyl,4-((4-dialkylaminophenyl)carbonyl)piperidines TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-03-15 — — US disclosed
US-5273974-A Condensed heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-12-28 — — US disclosed
EP-0378207-B1 CYCLIC AMINE COMPOUNDS AND THEIR USE Takeda Chemical Industries, Ltd. (JP) 1993-09-22 — — EP disclosed
US-5177087-A Cerebral edema, cholinesterase inhibitor TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-01-05 — — US disclosed
EP-0487071-A1 Condensed heterocyclic compounds, their production and use Takeda Chemical Industries, Ltd. (JP) 1992-05-27 — — EP disclosed
EP-0378207-A1 Cyclic amine compounds and their use Takeda Chemical Industries, Ltd. (JP) 1990-07-18 — — EP disclosed
Send feedback